China Irritable Bowel Syndrome (IBS) Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome (IBS) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Irritable Bowel Syndrome (IBS) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Irritable Bowel Syndrome (IBS) Overall Market Size
2.1 China Irritable Bowel Syndrome (IBS) Market Size: 2021 VS 2027
2.2 China Irritable Bowel Syndrome (IBS) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Irritable Bowel Syndrome (IBS) Players in China Market
3.2 Top China Irritable Bowel Syndrome (IBS) Companies Ranked by Revenue
3.3 China Irritable Bowel Syndrome (IBS) Revenue by Companies
3.4 Top 3 and Top 5 Irritable Bowel Syndrome (IBS) Companies in China Market, by Revenue in 2020
3.5 Companies Irritable Bowel Syndrome (IBS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Players in China Market
3.6.1 List of Tier 1 Irritable Bowel Syndrome (IBS) Companies in China
3.6.2 List of Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Irritable Bowel Syndrome (IBS) Market Size Markets, 2021 & 2027
4.1.2 IBS-D Drug
4.1.3 IBS-C Drug
4.1.4 Others
4.2 By Type - China Irritable Bowel Syndrome (IBS) Revenue & Forecasts
4.2.1 By Type - China Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
4.2.2 By Type - China Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
4.2.3 By Type - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Irritable Bowel Syndrome (IBS) Market Size, 2021 & 2027
5.1.2 Women
5.1.3 Men
5.2 By Application - China Irritable Bowel Syndrome (IBS) Revenue & Forecasts
5.2.1 By Application - China Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
5.2.2 By Application - China Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
5.2.3 By Application - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
6 Irritable Bowel Syndrome (IBS) Companies Profiles
6.1 Bausch Health
6.1.1 Bausch Health Company Details
6.1.2 Bausch Health Business Overview
6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
6.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.1.5 Bausch Health Recent Developments
6.2 Allergan
6.2.1 Allergan Company Details
6.2.2 Allergan Business Overview
6.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
6.2.4 Allergan Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.2.5 Allergan Recent Developments
6.3 Takeda
6.3.1 Takeda Company Details
6.3.2 Takeda Business Overview
6.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
6.3.4 Takeda Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.3.5 Takeda Recent Developments
6.4 Sucampo Pharmaceuticals (Mallinckrodt)
6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
6.5 Sebela Pharmaceuticals Inc
6.5.1 Sebela Pharmaceuticals Inc Company Details
6.5.2 Sebela Pharmaceuticals Inc Business Overview
6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
6.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.5.5 Sebela Pharmaceuticals Inc Recent Developments
6.6 Astellas Pharmaceuticals
6.6.1 Astellas Pharmaceuticals Company Details
6.6.2 Astellas Pharmaceuticals Business Overview
6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.6.5 Astellas Pharmaceuticals Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Irritable Bowel Syndrome (IBS) Market Opportunities & Trends in China Market
Table 2. Irritable Bowel Syndrome (IBS) Market Drivers in China Market
Table 3. Irritable Bowel Syndrome (IBS) Market Restraints in China Market
Table 4. Key Players of Irritable Bowel Syndrome (IBS) in China Market
Table 5. Top Irritable Bowel Syndrome (IBS) Players in China Market, Ranking by Revenue (2019)
Table 6. China Irritable Bowel Syndrome (IBS) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Irritable Bowel Syndrome (IBS) Revenue Share by Companies, 2016-2021
Table 8. Companies Irritable Bowel Syndrome (IBS) Product Type
Table 9. List of Tier 1 Irritable Bowel Syndrome (IBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 17. Bausch Health Company Details
Table 18. Bausch Health Business Overview
Table 19. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 20. Bausch Health Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Bausch Health Recent Developments
Table 22. Allergan Company Details
Table 23. Allergan Business Overview
Table 24. Allergan Irritable Bowel Syndrome (IBS) Product
Table 25. Allergan Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Allergan Recent Developments
Table 27. Takeda Company Details
Table 28. Takeda Business Overview
Table 29. Takeda Irritable Bowel Syndrome (IBS) Product
Table 30. Takeda Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Takeda Recent Developments
Table 32. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 33. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 34. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 35. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
Table 37. Sebela Pharmaceuticals Inc Company Details
Table 38. Sebela Pharmaceuticals Inc Business Overview
Table 39. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 40. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Sebela Pharmaceuticals Inc Recent Developments
Table 42. Astellas Pharmaceuticals Company Details
Table 43. Astellas Pharmaceuticals Business Overview
Table 44. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 45. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Astellas Pharmaceuticals Recent Developments
List of FiguresFigure 1. Irritable Bowel Syndrome (IBS) Segment by Type
Figure 2. Irritable Bowel Syndrome (IBS) Segment by Application
Figure 3. China Irritable Bowel Syndrome (IBS) Market Overview: 2020
Figure 4. China Irritable Bowel Syndrome (IBS) Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Irritable Bowel Syndrome (IBS) Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2020
Figure 7. By Type - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 8. By Application - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 9. Bausch Health Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Allergan Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Takeda Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)